Conformational search for the N6-substituted adenosine analogues and related adenosine A1 receptor antagonists

Bioorganic and Medicinal Chemistry

Volumn 4, Issue 6, 1996, Pages 917-921

  Dooley, Michael J ^a,b   Kono, Motomichi ^a   Suzuki, Fumio ^a  

^a KYOWA HAKKO KOGYO CO LTD   (Japan)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

6 N (1 ADAMANTYL)ADENOSINE; 6 N CYCLOPENTYLADENOSINE; ADENINE DERIVATIVE; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR AGONIST; ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE DERIVATIVE; CP 68247; CYCLOHEXYLADENOSINE; IMIDAZOQUINOLINE DERIVATIVE; LIGAND; PHENYLISOPROPYLADENOSINE; UNCLASSIFIED DRUG; XANTHINE DERIVATIVE; ADENOSINE; ADENOSINE RECEPTOR; DRUG DERIVATIVE;

ARTICLE; CALCULATION; CRYSTAL STRUCTURE; DRUG CONFORMATION; DRUG STRUCTURE; NUCLEAR MAGNETIC RESONANCE; QUANTUM MECHANICS; RECEPTOR AFFINITY; X RAY CRYSTALLOGRAPHY; CHEMISTRY; CONFORMATION; DRUG ANTAGONISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ADENOSINE; CRYSTALLOGRAPHY, X-RAY; MAGNETIC RESONANCE SPECTROSCOPY; NUCLEIC ACID CONFORMATION; RECEPTORS, PURINERGIC P1;

EID: 0029657868     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/0968-0896(96)00079-X     Document Type: Article

References (26)

1. Bruns, R. F. Nucleosides Nucleotides 1991, 10, 931.
2. Muller, C. E.; Scior, T. Pharmaceutica Acta Helvetiae 1993, 68, 77.
3. van Galen, P. J. M.; Stiles, G.; Michaels, G.; Jacobson, K. A. Medicinal Research Reviews 1992, 12, 423.
4. Suzuki, F. Drug News Perspect. 1992, 5, 587.
5. Shimada, J.; Suzuki, F.; Nonaka, H.; Ishii, A. J. Med. Chem. 1992, 35, 924.
6. Dooley, M. J.; Kono, M.; Suzuki, F. Bioorg. Med. Chem. 1996, 4, 923.
7. Van Galen, P. J. M.; Leusen, F. J. J.; Ijzerman, A. P.; Soudijn, W. Eur. J. Pharmacol.-Mol. Pharmacol. Sect. 1989, 172, 19.
8. CSD Sample Refcodes: ADGLAL10, BADFOB10, BARFUP, BERHAH, BODMOW, CATBII, DEFPOT, FIFMOW, GOJWOR, KEXKON, PUTRE, SACXEZ, VUGYOL.
9. Uzawa, J.; Anzai, K. Liebigs Ann. Chem. 1988, 12, 1195.
10. Escher, A.; Kennard, C. H. L.; Quinn, R. J.; Smith, G. Tetrahedron Lett, 1991, 32, 3583.
11. Bruns, R. F.; Lu, G. H.; Pugsley, T. A. Mol. Pharmacol. 1986, 29, 331.
12. Bruns, R. F.; Daly, J. W.; Snyder, S. H. Proc. Natl. Acad. Sci. U.S.A. 1980, 77, 5547.
13. Daly, J. W.; Padgett, W.; Thompson, R. D.; Kusachi, S.; Bugni, W. J.; Olsson, R. A. Biochem. Pharmacol. 1986, 35, 2467.
14. Londos, C.; Cooper, D. M. F.; Wolff, J. Proc. Natl. Acad. Sci. U.S.A. 1980, 77, 2551.
15. Sarges, R.; Howard, H. R.; Browne, R. G.; Lebel, L. A.; Seymour, P. A.; Koe, B. K. J. Med. Chem. 1990, 33, 2240.
16. Müller, C. E.; Hide, I.; Daly, J. W.; Rothenhäusler, K.; Eger, K. J. Med. Chem. 1990, 33, 2822.
17. Bruns, R. F.; Davis, R. E.; Ninteman, F. W.; Poschel, B. P. H.; Wiley, J. N. Adenosine and adenine nucleotides: physiology and pharmacology; Paton, D. M., Ed.; Taylor and Francis: London, 1988, pp 39-41.
18. Van Galen, P. J. M.; Nissen, P.; van Wijngaarden, I.; Ijzerman, A. P.; Soudijn, W. J. Med. Chem. 1991, 34, 1202.
19. CSD: Cambridge Crystallographic Data Centre, Lensfield Road, Cambridge, U.K.
20. QUANTA Molecular Simulations, Inc., 16 New England Executive Park, Burlington, MA 01803-5297, U.S.A.
21. Brooks, B. R.; Bruccoleri, R. E.; Olafson, B. D.; States, D. J.; Swaminathon, S.; Karplus, M. J. J. Comput. Chem. 1983, 4, 187.
22. (a) The AM1 Hamiltonian was chosen since it has been shown to be more accurate than MNDO/3 or MNDO with few exceptions. Dewar, M. J. S.; Zoebisch, E. G.; Healy, E. F.; Stewart, J. J. P. J. Am. Chem. Soc. 1985, 107, 3902;
23. 7
24. Stewart, J. J. P. MOPAC version 6.0. QCPE Bulletin 1983, 455.
25. 7 However the difference in results cannot be rationalized.
26. Uzawa, J.; Anzai, K. Can. J. Physiol. Pharmacol. 1987, 69, 2691.